ARADIGM CORP·4

Nov 5, 5:34 PM ET

Froehlich Juergen Kurt 4

4 · ARADIGM CORP · Filed Nov 5, 2018

Insider Transaction Report

Form 4
Period: 2018-10-26
Froehlich Juergen Kurt
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2018-10-26+60,000151,485 total
Footnotes (1)
  • [F1]Restricted stock award subject to repurchase by Aradigm Corporation until such time as such shares vest. The shares of restricted stock vest in four equal quarterly installments over a period of one year beginning on October 26, 2018, subject to the reporting person continuing to be a Participant (as defined in the Aradigm Corporation 2015 Equity Incentive Plan) on each relevant vesting date.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT